YLYeqian Liu

Yeqian Liu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Yeqian Liu has a total of 12 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Effect of Gouteng Jiangya Jieyu Prescription on Neuronal Damage in Rats With Hypertension Complicated by Depression via ROS/AKT/NF‐κB Pathway

    by Shan Gong, Yeqian Liu, Chunming Chen, Min Feng, Meiqi Yang, Weiqiong Ren

    Gouteng Jiangya Jieyu Prescription (GTJYJYP) shows potential in regulating blood pressure and improving mood. This study aims to investigate GTJYJYP's neuroprotective effects against neuronal damage and its underlying mechanisms in rats with hypertension complicated by depression (HD). Forty‐eight male SHR were randomly divided into SHR group, HD group, GTJYJYP low‐dose (6.34 g/kg), medium‐dose (12.69 g/kg), high‐dose group (25.38 g/kg), and a positive control group. And eight WKY rats were served as the control group. Blood pressure, depressive‐like behaviors and the contents of ROS, GSH, MDA TNF‐α, IL‐1β, IL‐6, and IL‐18 were measured. Hippocampal neuronal morphology was observed using HE and Nissl staining. Protein expression of ROS/AKT/NF‐κB pathway was detected by WB. Subsequently, ROS inducer H 2 O 2 and AKT inhibitor MK2206 were used for intervention, and the changes of the above indicators were observed. Compared to the control group, blood pressure in both SHR and HD group rats was significantly elevated. Compared to the control and SHR groups, rats in HD group exhibited depressive‐like behavior significantly. Furthermore, the HD group showed elevated levels of TNF‐α, IL‐1β, IL‐6, IL‐18, ROS, and MDA, along with reduced GSH levels significantly. Besides, the ratios of p‐NF‐κB p65/NF‐κB p65 and p‐AKT/AKT in HD group were increased significantly. Obvious neuronal damage was observed by Nissl staining. After the treatment of different doses of GTJYJYP and the positive drug, the damage was ameliorated. The ROS/AKT/NF‐κB pathway was significantly inhibited. H₂O₂ treatment reversed the protective effects of GTJYJYP, whereas MK2206 further enhanced the ameliorative effects of GTJYJYP on oxidative stress, inflammatory response, and neuronal damage. GTJYJYP ameliorates neuronal damage in rats with HD through ROS/AKT/NF‐κB pathway.

  • Open Access

    Mechanism and Pharmacodynamic Substance Basis of Raw and Wine-Processed Evodia rutaecarpa on Smooth Muscle Cells of Dysmenorrhea Mice

    by Yeqian Liu, Hong Li, Lei Chen, Hongxia Zhao, Jian Liu, Shan Gong, Danfeng Ma, Chunming Chen, Shuiqing Zeng, Hongping Long, et al.

    Objectives. Evodia rutaecarpa (ER) is a well-known herbal Chinese medicine traditionally used for analgesia in dysmenorrhea, headaches, abdominal pain, etc. Notably, the analgesic effect of wine-processed Evodia rutaecarpa (PER) was more potent than that of raw ER. This research aimed to investigate the mechanism and pharmacodynamic substance basis of raw ER and PER on smooth muscle cells of dysmenorrhea mice. Methods. Metabolomics methods based on UPLC-Q-TOF-MS were utilized to analyse the differential components of ER before and after wine processing. Afterwards, the uterine smooth muscle cells were isolated from the uterine tissue of dysmenorrhea and normal mice. The isolated dysmenorrhea uterine smooth muscle cells were randomly divided into four groups: model group, 7-hydroxycoumarin group (1mmol/L), chlorogenic acid (1mmol/L), and limonin (50μmol/L). The normal group consisted of the isolated normal mouse uterine smooth muscle cells, which were repeated 3 times in each group. The cell contraction and the expression of P2X3 and Ca2+ in vitro were determined using immunofluorescence staining and laser confocal; ELISA was used for detection of PGE2, ET-1, and NO content after 7-hydroxycoumarin, chlorogenic acid, and limonin administered for 24h. Results. The metabolomics results suggested that seven differential compounds were identified in the extracts of raw ER and PER, including chlorogenic acid, 7-hydroxycoumarin, hydroxy evodiamine, laudanosine, evollionines A, limonin, and 1-methyl-2-[(z)-4-nonenyl]-4 (1H)-quinolone. The in vitro results showed that 7-hydroxycoumarin, chlorogenic acid, and limonin were able to inhibit cell contraction and PGE2, ET-1, P2X3, and Ca2+ in dysmenorrhea mouse uterine smooth muscle cells and increase the content of NO. Conclusion. Our finding suggested that the compounds of the PER were different from those of the raw ER, and 7-hydroxycoumarin, chlorogenic acid, and limonin could improve dysmenorrhea in mice whose uterine smooth muscle cell contraction was closed with endocrine factors and P2X3-Ca2+ pathway.